UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

The New England journal of medicine, 2019-02, Vol.380 (8), p.711-719

2019

Volltextzugriff (PDF)

Screening for Occult Cancer in Unprovoked Venous Thromboembolism

The New England journal of medicine, 2015-08, Vol.373 (8), p.697-704

2015

Volltextzugriff (PDF)

What’s new in VTE risk and prevention in orthopedic surgery

Research and practice in thrombosis and haemostasis, 2020-03, Vol.4 (3), p.366-376

2020

Volltextzugriff (PDF)

In acutely ill inpatients, benefits and harms of anticoagulants for VTE prophylaxis were assessed

Annals of internal medicine, 2022-11, Vol.175 (11), p.JC128

Shivakumar, Sudeep

2022

Volltextzugriff (PDF)

Catheter-Associated Thrombosis in Patients With Malignancy

Journal of clinical oncology, 2009-10, Vol.27 (29), p.4858-4864

2009

Volltextzugriff (PDF)

Practical Considerations for the Management of Cancer-Associated Venous Thromboembolism: A Guide for the General Oncology Practitioner

Current oncology (Toronto), 2022-09, Vol.29 (9), p.6419-6432

2022

Volltextzugriff (PDF)

Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus

Current oncology (Toronto), 2021-12, Vol.28 (6), p.5434-5451

2021

Volltextzugriff (PDF)

MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial

BMJ open, 2021-09, Vol.11 (9), p.e049557-e049557

2021

Volltextzugriff (PDF)

A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

Pilot and feasibility studies, 2020-04, Vol.6 (1), p.52-52, Article 52

2020

Volltextzugriff (PDF)

Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

Pilot and feasibility studies, 2020-05, Vol.6 (1), p.67-67, Article 67

2020

Volltextzugriff (PDF)

Mixed phenotype acute leukemia, B/myeloid, NOS with near-tetraploidy: a case report

International journal of clinical and experimental pathology, 2017-01, Vol.10 (11), p.11206-11210

2017

Volltextzugriff (PDF)

TRanEXamic acid to decrease Heavy Menstrual Bleeding in individuals anticoagulated for venous thromboembolism (T-REX HMB): Health care practitioner survey

Thrombosis research, 2024-03, Vol.235, p.11-14

2024

Volltextzugriff (PDF)

A Case of Hepatosplenic Gamma-delta T Cell Lymphoma with Intravascular Lymphoma Like Features in a Young Male With Autoimmune Hepatitis: 762

The American journal of gastroenterology, 2015-10, Vol.110, p.S333-S334

2015

Volltextzugriff (PDF)

ACP Journal Club. Review: new oral factor Xa inhibitors reduce DVT compared with standard thromboprophylaxis after THR or TKR

Annals of internal medicine, 2014-01, Vol.160 (2), p.JC3

2014

Volltextzugriff (PDF)

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

BMJ (Online), 2021-10, Vol.375, p.n2400

2021

Volltextzugriff (PDF)

Perioperative Management of Dabigatran: A Prospective Cohort Study

Circulation (New York, N.Y.), 2015-07, Vol.132 (3), p.167-173

2015

Volltextzugriff (PDF)

The Development and Application of a Clinical Severity Scoring Model for Post-Operative Venous Thromboembolism (VTE)

Blood, 2019-11, Vol.134 (Supplement_1), p.1148-1148

2019

Volltextzugriff (PDF)

Natural History of Tumor Thrombus: A Single-Centre Retrospective Study

Blood, 2019-11, Vol.134 (Supplement_1), p.2430-2430

2019

Volltextzugriff (PDF)

Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study

Thrombosis and haemostasis, 2023-07, Vol.123 (7), p.692

2023

Volltextzugriff (PDF)

Step down to 6 months of prophylactic‐dose low molecular weight heparin after initial full‐dose anticoagulation for the treatment of cancer‐associated thrombosis (STEP‐CAT): A pilot study

Journal of thrombosis and haemostasis, 2022-08, Vol.20 (8), p.1868-1874

2022

Volltextzugriff (PDF)

Step down to 6months of prophylactic‐dose low molecular weight heparin after initial full‐dose anticoagulation for the treatment of cancer‐associated thrombosis (STEP‐CAT): A pilot study

Journal of thrombosis and haemostasis, 2022-08, Vol.20 (8), p.1868-1874

2022

Volltextzugriff (PDF)

Rivaroxaban for Improvement in Thromboembolism Outcomes in Patients with Multiple Myeloma on Lenalidomide-Based Therapy: The Rithmm Feasibility Pilot Trial

Blood, 2021-11, Vol.138 (Supplement 1), p.3232-3232

2021

Volltextzugriff (PDF)

Economic Evaluation of the Direct Oral Anticoagulants Compared to Vitamin K Antagonists in the Treatment of Deep Venous Thrombosis and Pulmonary Embolism in the Outpatient Setting: Analysis from the Queen Elizabeth II Health Sciences Centre in Halifax, Nova Scotia

Blood, 2016-12, Vol.128 (22), p.3528-3528

2016

Volltextzugriff (PDF)

Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial

Thrombosis research, 2022-08, Vol.216, p.8-10

2022

Volltextzugriff (PDF)

Survival disparities following surgery among patients with different histological types of non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2020-02, Vol.140, p.55-58

2020

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(59)
Berichte
(1)

Sprache

Englisch
(60)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

Screening for Occult Cancer in Unprovoked Venous Thromboembolism

What’s new in VTE risk and prevention in orthopedic surgery

In acutely ill inpatients, benefits and harms of anticoagulants for VTE prophylaxis were assessed

Catheter-Associated Thrombosis in Patients With Malignancy

Practical Considerations for the Management of Cancer-Associated Venous Thromboembolism: A Guide for the General Oncology Practitioner

Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus

MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial

A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

Mixed phenotype acute leukemia, B/myeloid, NOS with near-tetraploidy: a case report

TRanEXamic acid to decrease Heavy Menstrual Bleeding in individuals anticoagulated for venous thromboembolism (T-REX HMB): Health care practitioner survey

A Case of Hepatosplenic Gamma-delta T Cell Lymphoma with Intravascular Lymphoma Like Features in a Young Male With Autoimmune Hepatitis: 762

ACP Journal Club. Review: new oral factor Xa inhibitors reduce DVT compared with standard thromboprophylaxis after THR or TKR

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

Perioperative Management of Dabigatran: A Prospective Cohort Study

The Development and Application of a Clinical Severity Scoring Model for Post-Operative Venous Thromboembolism (VTE)

Natural History of Tumor Thrombus: A Single-Centre Retrospective Study

Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study

Step down to 6 months of prophylactic‐dose low molecular weight heparin after initial full‐dose anticoagulation for the treatment of cancer‐associated thrombosis (STEP‐CAT): A pilot study

Step down to 6months of prophylactic‐dose low molecular weight heparin after initial full‐dose anticoagulation for the treatment of cancer‐associated thrombosis (STEP‐CAT): A pilot study

Rivaroxaban for Improvement in Thromboembolism Outcomes in Patients with Multiple Myeloma on Lenalidomide-Based Therapy: The Rithmm Feasibility Pilot Trial

Economic Evaluation of the Direct Oral Anticoagulants Compared to Vitamin K Antagonists in the Treatment of Deep Venous Thrombosis and Pulmonary Embolism in the Outpatient Setting: Analysis from the Queen Elizabeth II Health Sciences Centre in Halifax, Nova Scotia

Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial

Survival disparities following surgery among patients with different histological types of non-small cell lung cancer

Suchergebnisse filtern